• P. N. Patsalos


Ethosuximide (Fig. 1) corresponds chemically to 2-ethyl-2-methylsuccinimide with an empirical formula of C7H11NO2 and a molecular weight of 141.7.


Valproic Acid Therapeutic Drug Monitoring Plasma Protein Binding Pharmacokinetic Interaction Absence Seizure 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1. 
    Giaccone M, Bartoli A, Gatti G, Marchiselli R, Pisani F, Latella MA, Perucca E. Effect of enzyme inducing anticonvulsants on ethosuximide pharmacokinetics in epileptic patients. Br J Clin Pharmacol. 1996;41:575–9.PubMedCrossRefGoogle Scholar
  2. 2. 
    Eriksson AS, Hoppu K, Nergardh A, Boreu L. Pharmacokinetic interactions between lamotrigine and other antiepileptic drugs in children with intractable epilepsy. Epilepsia. 1996;37:769–73.PubMedCrossRefGoogle Scholar
  3. 3. 
    Kasteleijn-Nolst Trenite DGA, Marescaux C, Stodieck S, Edelbroek PM, Oosting J. Evaluation of the piracetam analogue, levetiracetam. Epilepsy Res. 1996;25:225–30.PubMedCrossRefGoogle Scholar
  4. 4. 
    Battino D, Cusi C, Franceschetti S, Moise A, Spina S, Avanzini G. Ethosuximide plasma concentrations: influence of age and associated concomitant therapy. Clin Pharmacokinet. 1982;7:176–80.PubMedCrossRefGoogle Scholar
  5. 5. 
    Loiseau P, Duché B. Rolandic paroxysmal epilepsy or partial benign epilepsy in children. Rev Prat. 1988;38(18):1194–6.PubMedGoogle Scholar
  6. 6. 
    Pisani F, Narbone MC, Trunfio C, Fazio A, La Rosa G, Oteri G, Di Perri R. Valproic acid-ethosuximide interaction: a pharmacokinetic study. Epilepsia. 1984;25:229–33.PubMedCrossRefGoogle Scholar
  7. 7. 
    Rowan AJ, Meijer JW, de Beer-Pawlikowski N, van der Geest P, Meinardi H. Valproate-ethosuximide combination therapy for refractory seizures. Arch Neurol. 1983;40:797–802.PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag London 2013

Authors and Affiliations

  • P. N. Patsalos
    • 1
    • 2
  1. 1.UCL-Institute of Neurology Department of Clinical and Experimental EpilepsyLondonLondon
  2. 2.Epilepsy Society Chalfont Centre for EpilepsyBuckinghamshireUK

Personalised recommendations